BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15308724)

  • 1. Adaptive immunity is the primary force driving selection of equine infectious anemia virus envelope SU variants during acute infection.
    Mealey RH; Leib SR; Pownder SL; McGuire TC
    J Virol; 2004 Sep; 78(17):9295-305. PubMed ID: 15308724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease.
    Sponseller BA; Sparks WO; Wannemuehler Y; Li Y; Antons AK; Oaks JL; Carpenter S
    Virology; 2007 Jun; 363(1):156-65. PubMed ID: 17328936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.
    Mealey RH; Sharif A; Ellis SA; Littke MH; Leib SR; McGuire TC
    Virology; 2005 Aug; 339(1):110-26. PubMed ID: 15979679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of low-dose recombinant human IL-2 to support the survival of virus-specific CTL clones infused into severe combined immunodeficient foals: lack of correlation between in vitro activity and in vivo efficacy.
    Mealey RH; Littke MH; Leib SR; Davis WC; McGuire TC
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):8-22. PubMed ID: 17727961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.
    Leroux C; Craigo JK; Issel CJ; Montelaro RC
    J Virol; 2001 May; 75(10):4570-83. PubMed ID: 11312327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.
    Lonning SM; Zhang W; Leib SR; McGuire TC
    J Virol; 1999 Apr; 73(4):2762-9. PubMed ID: 10074123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses.
    Mealey RH; Fraser DG; Oaks JL; Cantor GH; McGuire TC
    Clin Immunol; 2001 Nov; 101(2):237-47. PubMed ID: 11683583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
    Howe L; Leroux C; Issel CJ; Montelaro RC
    J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of broadly neutralizing immunoglobulin against homologous and heterologous equine infectious anemia virus infection in horses with severe combined immunodeficiency.
    Taylor SD; Leib SR; Wu W; Nelson R; Carpenter S; Mealey RH
    J Virol; 2011 Jul; 85(13):6814-8. PubMed ID: 21543497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of a rare neutralization-resistant variant following passive transfer of convalescent immune plasma in equine infectious anemia virus-challenged SCID horses.
    Taylor SD; Leib SR; Carpenter S; Mealey RH
    J Virol; 2010 Jul; 84(13):6536-48. PubMed ID: 20392850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Horses naturally infected with EIAV harbor 2 distinct SU populations but are monophyletic with respect to IN.
    Cervantes DT; Ball JM; Edwards J; Payne S
    Virus Genes; 2016 Feb; 52(1):71-80. PubMed ID: 26739458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse.
    Zheng YH; Nakaya T; Sentsui H; Kameoka M; Kishi M; Hagiwara K; Takahashi H; Kono Y; Ikuta K
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():807-20. PubMed ID: 9129653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Envelope-specific T-helper and cytotoxic T-lymphocyte responses associated with protective immunity to equine infectious anemia virus.
    Tagmyer TL; Craigo JK; Cook SJ; Issel CJ; Montelaro RC
    J Gen Virol; 2007 Apr; 88(Pt 4):1324-1336. PubMed ID: 17374779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural variation of equine infectious anemia virus Gag protein cytotoxic T lymphocyte epitopes.
    Zhang W; Auyong DB; Oaks JL; McGuire TC
    Virology; 1999 Sep; 261(2):242-52. PubMed ID: 10497109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced sensitivity to neutralizing antibodies in a variant of equine infectious anemia virus is linked to amino acid substitutions in the surface unit envelope glycoprotein.
    Cook RF; Berger SL; Rushlow KE; McManus JM; Cook SJ; Harrold S; Raabe ML; Montelaro RC; Issel CJ
    J Virol; 1995 Mar; 69(3):1493-9. PubMed ID: 7853482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Zhou J
    Virus Genes; 2011 Apr; 42(2):220-8. PubMed ID: 21369830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.
    Mealey RH; Zhang B; Leib SR; Littke MH; McGuire TC
    Virology; 2003 Sep; 313(2):537-52. PubMed ID: 12954220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies.
    Cook RF; Cook SJ; Bolin PS; Howe LJ; Zhou W; Montelaro RC; Issel CJ
    Vet Microbiol; 2005 Jun; 108(1-2):23-37. PubMed ID: 15885929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule.
    McGuire TC; Leib SR; Mealey RH; Fraser DG; Prieur DJ
    J Immunol; 2003 Aug; 171(4):1984-93. PubMed ID: 12902502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
    Leroux C; Issel CJ; Montelaro RC
    J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.